ARVN vs ZTS · rev $265.3M vs P/E 25, rev $2.47B
Arvinas Inc (ARVN) versus Zoetis Inc (ZTS) — a side-by-side from cached financials, not a winner call.
Arvinas Inc (ARVN) is a biotechnology company listed on US.
Zoetis Inc (ZTS) is a drug manufacturers - specialty & generic company listed on US.
Latest reported ARVN revenue for 2026-06-30 was $265.3M. Net income was $111.8M. ARVN currently screens at market cap $478.7M.
Latest reported ZTS revenue for 2026-06-30 was $2.47B. Net income was $691.0M. Revenue was up 9.1% from 2026-03-31 to 2026-06-30. ZTS currently screens at market cap $64.65B and trailing P/E 24.9.
ARVN currently screens at market cap $478.7M. ZTS currently screens at market cap $64.65B and trailing P/E 24.9.
Not investment advice. Open the ARVN and ZTS stock pages for the full models.
Not investment advice.